Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene

Gene therapy has promising applications in ovarian cancer therapy. Blocking the function of the survivin protein could lead to the growth inhibition of cancer cells. Herein, we used degradable heparin–polyethyleneimine (HPEI) nanoparticles to deliver a dominant-negative human survivin T34A (hs-T34A)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Nanomedicine
Egile Nagusiak: Luo, Li, Du, Ting, Zhang, Jiumeng, Zhao, Wei, Cheng, Hao, Yang, Yuping, Wu, Yujiao, Wang, Chunmei, Men, Ke, Gou, Maling
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4745847/
https://ncbi.nlm.nih.gov/pubmed/26893558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S93496
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak